Stock screenerAll disclosures →
EDGAR →
CVS
Conviction 44HealthcareScan · Tue, Sep 8, 2026CVS$96.10-0.66%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 6.09M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price96.10
Change-0.66%
Gap-1.11%
Rel volume0.76×
Avg volume6.59M
Avg $ vol624.67M
SMA 2094.79
SMA 50100.63
SMA 20086.64
Price vs 50-4.50%
Price vs 200+10.91%
MA stackmixed
50/200 cross—
Supertrenddown · 99.75
RSI (14)48
MACD hist0.66
MACD crossbull · 5d
Stoch %K / %D61 / 70
ADX (14)25
+DI / −DI20 / 22
RSI divergenceBullish
MACD divergenceBullish
ATR %+2.25%
ADR %2.03%
52w high110.60
52w low70.08
From 52w high-13.11%
Above 52w low+37.13%
New 52w highNo
SqueezeOff
Bollinger width6.70%
%B0.71
Donchian pos60.98%
Donchian high98.50
Donchian low92.35
AVWAP (52w high)98.49
vs AVWAP high-2.43%
AVWAP (52w low)93.91
vs AVWAP low+2.33%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d0.76×
Avg vol (14d)6.09M
Avg vol (20d)6.59M
Avg $ vol (20d)624.67M
Market cap122.91B
RS 3m (vs SPY)-3.58%
RS 6m (vs SPY)+9.61%
RS line new highNo
Trend template6/8
Technical rank64.4
1 week+2.33%
1 month+0.42%
3 months-1.01%
6 months+22.80%
1 year+30.25%
YTD+19.93%
P/E69.52
P/B1.54
P/S0.63
P/FCF15.74
EPS1.39
Div yield2.76%
ROE2.22%
ROA0.70%
Debt/Eq0.90
Current0.87
EV/EBITDA19.78
Gross margin14.72%
Net margin0.91%
Rev growth4.95%
EPS growth-61.68%
Price target114.37
Target upside19.01%
Analyst ratingBuy
Institutional99.53%
Ent. value183.25B
Revenue64.55B
Net income2.98B
Gross profit7.33B
Free cash flow7.81B
IndustryRETAIL-DRUG STORES AND PROPRIETARY STORES
ExchangeNYSE
Shares out1.28B
Employees300K
ListedWed, Oct 1, 1952
Free float1.26B
Float %99.3%
Short interest16.82M
Days to cover1.8d
Short volume33.8%
Squeeze score12 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.58 vs $1.87
Last surprise+38.0% beat
Setup gradeD
Conviction44 / 100
Pattern quality—
Tech rank64.4 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance110.34
Support92.74
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CVS · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-08-26 | Sell | $1K–$15K | 2024-08-26 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 John Boozman senate · R · AR · traded 2026-01-29 | Buy | $1K–$15K | 2026-01-29 | 2026-02-15 | |
 Dwight Evans house · PA · traded 2025-11-21 | Sell | $1K–$15K | 2025-11-21 | 2025-12-05 | |
 Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
 Adam Smith house · D · WA · traded 2025-08-08 | Sell | $1K–$15K | 2025-08-08 | 2025-08-08 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 |
Insider activity
SEC Form 4 transactions in CVS · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Clark James David SVP, Cont & Chief Acct Officer · Common Stock (Restricted) · 2026-06-26 | Tax | 454 | $41K | 2026-06-26 | 2026-06-29 |
Newman Brian EVP, Chief Financial Officer · Common Stock · 2026-05-31 | Tax | 2.48K | $225K | 2026-05-31 | 2026-06-01 |
Compton-Phillips Amy EVP, Chief Medical Officer · Common Stock · 2026-05-31 | Tax | 7.62K | $693K | 2026-05-31 | 2026-06-01 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-21 | Disposition | 1.56K | $146K | 2026-05-21 | 2026-05-22 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-20 | Disposition | 30.44K | $2.9M | 2026-05-20 | 2026-05-22 |
ROBBINS LARRY Director · Cash-Settled Swaps · 2026-05-21 | Sell | 378K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-21 | Sell | 370.46K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 797.63K | $75M | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 800 | $77K | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 66.88K | $6.4M | 2026-05-20 | 2026-05-21 |
SEC filings
EDGAR filings in CVS · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.